Načítá se...
Drug switching in the Netherlands: a cohort study of 20 active substances
BACKGROUND: For a patient, drug switches are not desirable (either between a brand-name drug and a generic drug, or between two generic drugs of the same active substance). Research into the causes of drug switches, and related adverse drug reactions, is hampered by the absence of quantitative data...
Uloženo v:
| Vydáno v: | BMC Health Serv Res |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359503/ https://ncbi.nlm.nih.gov/pubmed/32660480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-020-05494-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|